Correlation Between Novo Nordisk and OMX Copenhagen

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and OMX Copenhagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and OMX Copenhagen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and OMX Copenhagen All, you can compare the effects of market volatilities on Novo Nordisk and OMX Copenhagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of OMX Copenhagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and OMX Copenhagen.

Diversification Opportunities for Novo Nordisk and OMX Copenhagen

0.87

Correlation Coefficient

Novo Nordisk  OMX Copenhagen

Very poor diversification

The 3 months correlation between Novo and OMX is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and OMX Copenhagen All in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OMX Copenhagen All and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with OMX Copenhagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OMX Copenhagen All has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and OMX Copenhagen go up and down completely randomly.

Pair Corralation between Novo Nordisk and OMX Copenhagen

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the OMX Copenhagen. In addition to that, Novo Nordisk is 1.66 times more volatile than OMX Copenhagen All. It trades about -0.17 of its total potential returns per unit of risk. OMX Copenhagen All is currently generating about -0.18 per unit of volatility. If you would invest  195,018  in OMX Copenhagen All on August 30, 2024 and sell it today you would lose (25,310) from holding OMX Copenhagen All or give up 12.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.46%
Values	Daily Returns

Novo Nordisk AS  vs.  OMX Copenhagen All

Pair Trading with Novo Nordisk and OMX Copenhagen

The main advantage of trading using opposite Novo Nordisk and OMX Copenhagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, OMX Copenhagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OMX Copenhagen will offset losses from the drop in OMX Copenhagen's long position.

The idea behind Novo Nordisk AS and OMX Copenhagen All pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.